HIV prophylaxis

HIV prophylaxis

AIDS The administration of one–eg, zidovudine or more anti-HIV agents after contact with HIV-infected blood. See HAART, HIV.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Kenya's guidelines on the prevention of mother-to-child transmission of HIV/Aids emphasise early initiation of HIV prophylaxis, starting as early as at 14 weeks of pregnancy or earlier depending on the viral load of the mother.
No individual potential conflicts of interest were disclosed; however, CDC and other CDC staff are named in US government patents and patent applications related to methods for HIV prophylaxis.
"Payers who have injured workers with occupational exposure to needle-sticks often include HIV medications on their formulary to ensure quick access to work-related HIV prophylaxis therapy," Nelson said.
(27) found 87.6% of treatments within 72 hours with the prescription of HIV prophylaxis for 84% of treatments, 82.5% for hepatitis B and 86.5% for bacterial STIs, while Andalaft et al.
HEIs who received NVP syrup for HIV prophylaxis after 6 weeks of birth had equal chances of HIV transmission compared to those who never received NVP syrup for HIV prophylaxis (AOR = 1).
"Furthermore, if there is an HIV-infected infant who received HIV prophylaxis with zidovudine and nevirapine, the infant may have developed resistance to the nonnucleoside reverse transcriptase inhibitors [NNRTIs] class of medications, and timely antiretroviral-resistant testing is an important step prior to choosing an appropriate regimen," Nava Yeganeh, MD, said in an interview prior to an annual scientific meeting on infectious diseases.
* On-demand HIV prophylaxis. Our PURL for the month discusses an effective prevention strategy--other than condoms--that can be used as needed by people at high risk for human immunodeficiency virus.
In creating the groups for the secondary analysis dyads were excluded if the reason for newborn HIV prophylaxis was driven by the mother's partner being HIV-positive while the mother herself was HIV-negative, and an additional dyad was excluded as there was no ascertainable viral load data for the duration of the mother's pregnancy at the time the retrospective chart review was performed.
One of the two drug combinations tested in the ring had been shown in three clinical trials to prevent HIV-some of the time-when taken orally, and is the only product approved by the US Food and Drug Administration (FDA) for HIV prophylaxis.
Out of 35 healthcare workers who had past experience of NSI, only 4(11%) HCWs reported NSI incident to reporting authority and received PEP for HIV prophylaxis
Completed observation of the randomized placebo-controlled phase of iPrEx: daily oral FTC/TDF pre-exposure HIV prophylaxis among men and trans women who have sex with men.